RFK Jr. Appoints High-Profile COVID Shot Skeptic To Vaccine Committee
Robert Malone, one of the eight new members named by Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday to serve on the committee tasked with advising the U.S. government on vaccines, has a long track record of sharing conspiracy theories about life-saving COVID shots.
Malone, a former mRNA researcher who also runs a blog on Substack with over 357,000 subscribers that he has used to spread COVID misinformation, gained prominence spreading baseless claims about the pandemic, including in an interview on Joe Rogan's podcast in December 2021.
During the three-hour sitdown, Malone falsely suggested that former President Joe Biden lied about being vaccinated for COVID while receiving his booster on live TV, and claimed that Israel, where over two-thirds of the population had received the vaccine, had a higher mortality rate than Gaza and the West Bank, which had lower vaccination rates, despite figures pointing to the contrary, according to The New York Times. He also drew a comparison between the country's pandemic policies and medical experiments in Nazi Germany, and accused Dr. Anthony Fauci of hypnotizing a third of the U.S. population into believing his recommendations on COVID.
Over 270 scientists, medical professionals, professors and science communicators wrote to Spotify, the company hosting Rogan's podcast, calling on the company to moderate misinformation on the platform, citing the Malone interview as an example of damaging public trust in scientific research.
Malone's account on X, formerly Twitter, was also suspended shortly before that interview after he posted a video on the platform questioning the safety of the Pfizer vaccine. It has since been restored.
Separately, Malone has also baselessly suggested that COVID vaccines are 'not working' and could damage children's brains, hearts and immune system, and also cause a form of AIDS, according to The Associated Press, another false claim.
Besides, Malone, who has a medical degree from Northwestern University, claims he is the inventor of mRNA vaccines — a statement that is widely disputed by scientists, including some who worked closely with him, according to the Times.
Kennedy, a fellow prominent vaccine skeptic, on Monday penned an op-ed in The Wall Street Journal announcing he was removing all members of the Advisory Committee for Immunization Practices, which is tasked with assessing the safety and efficacy of vaccines to curb the spread of diseases.
'A clean sweep is needed to re-establish public confidence in vaccine science,' Kennedy wrote.
Two days later, he announced eight new members for the panel, including Malone, a move he claimed would help restore the public's faith in vaccines.
'I will do my best to serve with unbiased objectivity and rigor,' Malone said in response to his new assignment.
RFK Jr. Drops All Members Of U.S. Vaccine Advisory Panel
Top COVID Vaccine Adviser Quits After RFK Jr. Changes Recommendations
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
an hour ago
- CBS News
Chicago doctor Cathy Creticos has been at the forefront of HIV/AIDS research and treatment for decades
Dr. Cathy Creticos with the Howard Brown Health Center has been at the forefront of HIV and AIDS research and treatment for decades, saving countless lives. She has also been an ally to the LGBTQ+ community and, according to her patients, a friend. They call her Dr. C, with love, and she says the feeling is mutual. "She's in that list of people I'm thankful for every day of my life," said Madrid St. Angelo. "She literally has been a lifeline for me." St. Angelo is an actor, artistic director and instructor, and he's been living with HIV/AIDS for almost 30 years. "I met Dr. C in 1992 when I was very, very sick and since that time she literally has guided me every step of the way on my wellness journey," he said. Creticos has headed up the team at Chicago's Howard Brown Health Center since 1995, but she has been at the forefront of HIV/AIDS research and treatment since the very beginning. Dr. Creticos' father was a physician whose name is on the cancer center at Illinois Masonic Medical Center, but she didn't want to be a doctor originally. "I had an awakening, I heard a voice kind of thing, it just all gelled for me," she said. "Being a physician was something I could do to really contribute in a more concrete, meaningful way." After attending medical school at the University of Chicago, she specialized in infectious disease at the University of Illinois, a field she found intriguing. "You actually can cure most infectious diseases, many infectious diseases," Creticos said. "Then we ran head first into HIV and that was the opposite what I thought infectious disease was going to be about." It was 1984, and no one even had a name for the mysterious, complicated virus that devastated the body's immune system, taking lives at rapid speed. Creticos became a part of a team working on the very first HIV medication trial testing AZT, the first drug approved to treat the virus. "It was very interesting," she said. "My patients were just amazing people. So resilient, so full of hope and courage, and determination to still live life despite having a very difficult diagnosis." As breakthroughs in treatment slowly came, so did joy. "I literally saw people who were comatose and even unable to raise their head off the bed returning to a full life," Creticos said. "That type of transformation was an amazing experience. I loved being part of that." But barriers to care remain, even today. "Probably one of the biggest barriers is our messed-up health system. Even patients who want to take their medicine and do it every day, their job changes, their insurance changes and prior authorization changes, so the meds they're taking are no longer authorized," she said. And the stigma around HIV/AIDS persists as well. "It still is a very pervasive, persistent problem," she said. "HIV is a virus. It can infect anybody. Anybody. And there's nothing particular about a certain type of people, that's just hogwash." Creticos said that's why education is crucial. "People who are sexually active, who don't consider themselves in a category at risk for HIV are not open to the idea of pre-exposure prophylaxes," she said. Those are the "PreP" medications that block HIV from taking hold and spreading. While Creticos and her team know an HIV vaccine may be a way's off, there is hope in the future. "There are some really impressive results in terms of getting the patient's immune system required to control the virus without medication," she said. But she said no treatment is complete without the personal touch and the compassion patients deserve. "She's a friend, she's a mentor, she's an inspiration," St. Angelo said. "I've told her many times I would not be here today if it weren't for you. I thank you from the bottom of my heart." Creticos said she first wanted to be a humanities professor, but she's so happy she heard the voice that told her to change her plans. Do you know someone a person or place that brings you joy? We want to share your story. Send us your "Eye on Chicago" ideas using the form below (or clicking here):
Yahoo
2 hours ago
- Yahoo
Viking Therapeutics (VKTX) Rises on Expected Developments
We recently published a list of . In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other top-performing companies on Tuesday. Viking Therapeutics grew its share prices by 5.69 percent on Tuesday to finish at $29.14 apiece as investors loaded up positions while waiting for fresh catalysts from the series of global conferences that it is participating in this month. At present, investors are expecting updates and developments from the three-day 46th Annual Goldman Sachs Global Healthcare Conference in Florida on June 9 to 11. It is also set to participate in a one-on-one meeting at the Scotiabank Third Annual Healthcare Canadian Investor Day on June 17. In April this year, Viking Therapeutics, Inc. (NASDAQ:VKTX) soared following news that its competitor, Pfizer Inc., discontinued the development of its oral obesity medication, danuglipron, amid safety concerns. According to PFE, the decision came after a patient experienced a potential liver injury linked to the drug. A microbiologist in protective gear studying samples in a laboratory. The scrapped plans, however, spelled good news for Viking Therapeutics, Inc. (NASDAQ:VKTX), which is similarly underway with the development of an oral weight loss candidate called VK2735, with Pfizer Inc. now out of the competition. Overall, VKTX ranks 8th on our list of top-performing companies on Tuesday. While we acknowledge the potential of VKTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Trump quips 'they didn't die of COVID' when asked if Israel killed Iranian officials
President Donald Trump joked on Friday morning about the fate of Iranian officials in the wake of Israel's recent airstrike, according to CNN's Dana Bash. After months of negotiations between the U.S. and Iran, Israel attacked Iran's nuclear and missile infrastructure early Friday, taking out at least 20 senior Iranian commanders and inflicting a significant blow to Tehran's government. Two of the most prominent officials killed in the strikes were Gen. Hossein Salami, the leader of the Islamic Revolutionary Guard Corps (IRGC) and Gen. Mohammad Bagheri, the chief of staff of the Iranian armed forces. Bash spoke on Friday about her phone call with Trump, where she asked him about Secretary of State Marco Rubio's initial statement about Israel's strikes, which did not explicitly say that the U.S. supported them. Trump Believes Israel's Strike On Iran Could Improve Chances For Nuclear Deal: Report "We, of course, support Israel, obviously, and supported it like nobody has ever supported it," Trump said, according to Bash. "It was a very successful attack. Iran should have listened to me when I said - you know, I gave them, I don't know if you know, but I gave them a 60-day warning. And today is day 61." "They should now come to the table to make a deal before it's too late. It will be too late for them. You know, the people I was dealing with are dead," he added, though he wouldn't give specific names, only that the "hardliners" were dead. Read On The Fox News App "This is as a result of the attack last night?" Bash asked him. "Yeah. They didn't die of the flu. They didn't die of COVID," Bash described him saying "quite sarcastically." Click Here For More Coverage Of Media And Culture Trump also told Fox News' Bret Baier on Friday that "The Iranians were hit 10 times worse than they thought they would be." "They weren't ready to negotiate. I think they may be now. We'll see," Trump said regarding the future of Iran's nuclear program. Senior U.S. officials told Fox News that a long list of nuclear scientists and military leaders were targeted by Israel's surprise airstrikes Friday. The officials added that 90% of Iran's top nuclear scientists, as well as other senior military officers and other Iranian leaders, may have been targeted in the article source: Trump quips 'they didn't die of COVID' when asked if Israel killed Iranian officials
